Is Silica in Toothpaste Safe? Abrasiveness, Enamel Effects and Safety

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: What Is White Carbon Black? Precipitated Silica Uses in Rubber and Tires
  • Keywords: Chinese fumed silica vs Aerosil
  • Published: 2026-11-20 03:05:13
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
The skin is our largest organ, which consists of three layers: the epidermis, dermis, and hypodermis. Owing to its big surface zone, it also serves as an essential gateway for drug administration [ 25 ], which is fitting for both local (dermal) or systemic (transdermal) therapy [ 25, 56 ]. In spite of the popularity of this administration route, it is a challenge to get the API into deeper layers of the skin. The outermost layer of the epidermis, the stratum corneum, is the biggest hurdle to molecular penetration [ 25, 56 ]. However, the molecules must be absorbed through the capillaries of the dermis to achieve a systemic impact, which can be facilitated employing nanocarriers [ 56 ]. In addition, sweat glands or hair follicles can be effective alternative routes for the molecules to enter the deeper layers of the skin [ 25, 56 ]. In summary, it can be called as the transappendageal route. Among physicochemical properties, particle size is one of the most vital factors influencing absorption. Particles in the range between 200 and 300 nm are suitable for local treatment of the skin in diseases such as atopic dermatitis [ 25 ] since particles larger than 75 nm do not pass through the stratum corneum [ 25 ]. Smaller particles (approximately 50 nm) are suitable for systemic treatment [ 25 ], and on the whole, it can be said that nanoparticles with a diameter smaller than 25 nm can penetrate the skin most effectively, so they can be used for transdermal drug administration with an appropriate formulation [ 56 ]. By controlling the size of the nanocarrier, they penetrate to different depths in the skin. From the element of surface characteristics, cationic amino-functionalized MSNs show more efficient penetration into deeper layers of the skin than the particles with anionic surfaces of the same size [ 25 ]. The use of MSNs as a drug carrier may improve aqueous solubility, stability, and skin penetration of the drug [ 61 ]. In a research, gels containing MSN were prepared by employing distilled water to form the base, adding the gelling agent (Poloxamer 407), and adding HPMC to enhance the viscosity [ 83 ]. In another publication, MSN containing oleogels were prepared with sunflower oil and the addition of colloidal silicon dioxide as a gelling agent [ 61 ]. According to in vitro experiments, the gel matrix also affected the drug release kinetics [ 61, 83 ]. Slower drug release was observed in the case of gels containing loaded MSNs, compared to the free carriers, and the outcomes demonstrated close to zero-order release kinetics [ 61 ]. According to in vitro biocompatibility studies, this gel complex did not show any evidence of cytotoxicity on dermal fibroblast cells. Moreover, according to in vivo dermal safety studies, it has been proven that this preparation does not cause skin irritation during application, and so this formulation can be considered a safe product [ 61 ].

Silica Supply Chain: Raw Materials, Production Hubs and Risks

Fused Silica Powder: Purity, Particle Sizes, CTE and Electronic Applications
MSNs are SiO 2 nanoparticles [ 2 ] with a pore diameter between 2 and 50 nm [ 3, 4 ] and with a total diameter of a maximum of 1 µm. Their use in drug delivery dates to the early 1990s when they were synthesized for various scientific applications [ 5 ]. The material known as mesoporous silica was discovered by Mobil Oil Corporation in 1992 [ 6 ]. Their first drug delivery application was demonstrated in 2001 when MCM-41 silica was used to release ibuprofen [ 7 ]. Since then, MSNs have become an increasingly popular drug delivery system due to their advantageous properties and have been typically recognized as secure (GRAS) by the FDA. Tiny SNPs have been approved for human clinical imaging studies, setting the stage for their use in clinical applications of drug delivery. The number of related research activities is continuously increasing each year, expanding their role in cancer treatment, gene delivery, and oral illness therapy [ 5 ]. Their pore size is located between microporous and macroporous systems. They can be used in diverse shapes (sphere, cube, ellipsoid, rod) and sizes, with different pore sizes and pore structures [ 2, 3, 4, 8, 9, 10 ]. They have a high degree of stability [ 8 ] and a rigid framework, which results in resistance to temperature, pH, enzymatic degradation, and mechanical force [ 4 ]. Thanks to the large number of pores, they have a massive particular surface region (approx. 700-1300 m 2 /g) and pore volume (approx. 0.5-1.5 cm 3 /g), which enables effective adsorption of diverse molecules [ 2, 3, 4, 8, 9, 10 ]. By changing the pore size distribution, the range of adsorbable molecules can be controlled [ 3 ], which also lets separation based on size exclusion, which means selective adsorption of molecules of certain sizes. Depending on the size of the pores, tiny molecules together with high molecular weight proteins can be transported into the pores [ 8 ]. In addition, chemical separation is also possible if the surface of the pores is coated with specific functional groups [ 4 ], which enables the separation of the APIs according to their structure [ 4 ]. Such modifications may include the setting of hydrophilicity/hydrophobicity of the surface, depending on whether the adsorption of hydrophobic or hydrophilic molecules is targeted [ 4 ]. By inserting different functional groups, the surface charge can also be controlled so that certain molecules will bind more efficiently. MSNs have a negative surface charge in biological environments, which promotes the electrostatic adsorption of positively charged APIs in the pores [ 10 ]. Moreover, the biological markers attached to the surface of the nanoparticles enable the drug-carrying system to deliver the API in a tissue-specific manner [ 2, 4, 8, 9, 10 ]. A substantial problem is the premature release of the API from the pores during transport [ 4, 8 ], which can be solved by utilizing gatekeepers that respond to special stimuli and keep the pores closed until the stimulus [ 2, 4, 8 ]. In this way, controlled drug delivery and stimuli-responsive release can be achieved [ 2, 4, 9 ]. The drug release could be triggered by temperature, pH, redox potential, light, enzymes, magnetic field, or different ligands [ 4, 8, 11 ].
What Is Crystalline Silica? Forms, Health Risks and Where It Is Used
21. Talekar S., Dave R. Solubility Enhancement of a BCS Class II Drug Employing Granulated Fumed Silica as an Adsorbent. J. Pharm. Res. Int. 2017;18:1-15. doi: 10.9734/JPRI/2017/36872. [ DOI ] [ Google Scholar ]
What Is Silicosis? Causes, Symptoms, Prevention and Silica Exposure
In spite of the advantages of solvent-free processes, solvent-based techniques offer a more widespread choice for filling the pores of the carriers. Each method listed here consists of two steps. First, mixing the drug solution and carrier, then removing the solvent [ 36 ]. The loading cycles can be repeated as many times as desired to increase the charging efficiency [ 20, 36 ]. These techniques can be effectively applied to molecules both with great and poor aqueous solubility [ 37 ]. However, removing the solvent residue at the end of the process is essential, owing to the toxicity of usually used organic solvents [ 56 ], and it is normally better to select a less toxic organic solvent, if possible [ 37, 56 ]. The adsorption of the API is also influenced by the properties of the solvent, such as viscosity or surface tension. This group includes the adsorption approach, the incipient wetness approach, the solvent evaporation method, and the use of liquid and supercritical CO 2. The adsorption technique (solvent immersion method) is a low-energy process, but the pores can be filled effectively only if the API reaches a high concentration in the solvent [ 37 ]. The carrier system is immersed in the concentrated drug solution, while the liquid fills the pores owing to capillary forces. The mesopores are then separated from the solution by filtration or centrifugation. Finally, the pores are dried under reduced pressure [ 2, 36, 37 ]. Drug loading abilities can be seen for some APIs by this loading approach, in the following figure ( Figure 1 ). During the incipient wetness impregnation, a greatly concentrated drug solution is added dropwise onto the surface of the mesopores, in a nearly equal volume to the pore volume of the carrier [ 37 ]. In this case, the pores are filled with liquid also owing to the capillary forces. Then the pores are dried out at a higher temperature and under reduced pressure [ 2, 36, 37 ]. Nevertheless, the third approach, solvent evaporation, is the most widely used because it can be applied to a wide range of molecules, regardless of their solubility, making it fitting for higher therapeutic doses as well. It is not necessary to prepare a concentrated solution since the concentration gradually increases during the process (owing to the evaporation of the solvent). During the process, the drug should be dissolved in a volatile organic solvent, which is mixed with the carrier system [ 20 ]. All solvents are then eliminated by quick evaporation [ 37 ], while the drug is absorbed into the pores of the drug carrier [ 36, 37 ]. The use of supercritical CO 2 brings about more productive and deeper pore filling compared to other solvents. In this state, neither a liquid phase nor a gas phase exists. It combines the brilliant diffusion capacity of gases and the excellent solvation capacity of liquids. In addition, it is non-toxic, non-flammable, and can be readily eliminated from the system. A cost-effective choice can be liquid CO 2, which is a similarly effective solvent [ 36, 37 ].
High Purity Quartz Market 2026: Supply, Demand and Price Outlook
42. Ortega E., Ruiz M.A., Peralta S., Russo G., Morales M.E. Improvement of mesoporous silica nanoparticles: A new approach in the administration of NSAIDS. J. Drug Deliv. Sci. Technol. 2020;58:101833. doi: 10.1016/j.jddst.2020.101833. [ DOI ] [ Google Scholar ]

Silica for Tires: How It Reduces Rolling Resistance and Improves Wet Grip

What is silica (SiO₂)?

wollastonite 44. Trzeciak K., Chotera-Ouda A., Bak-Sypien I.I., Potrzebowski M.J. Mesoporous silica particles as drug delivery systems - The state of the art in loading techniques and the recent progress in analytical approaches for monitoring these processes. Pharmaceutics. 2021;13:950. doi: 10.3390/pharmaceutics13070950. [ DOI ] [ PMC free post ] [ PubMed ] [ Google Scholar ]

What is the difference between fumed silica and precipitated silica?

quartz sand supplier MDPI and/or the editor(s) disclaim responsibility for any injury to individuals or property resulting from any ideas, methods, instructions or products referred to in the content.

What drives silica raw material prices?

325 mesh silica

Cite this article: Silica Raw Materials News. "Silica and Sodium Hydroxide Reaction: Equation, Products and Applications ." Published 2026-11-20 03:05:13. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.